Cargando…

Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes

AIMS: Optimal management of heart failure with reduced ejection fraction (HFrEF) includes titration of guideline‐directed medical therapy (GDMT) to the highest tolerated dose within the licensed range. During hospitalization, GDMT doses are often significantly altered, although it is unknown whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palin, Victoria, Drozd, Michael, Garland, Ellis, Malik, Anam, Straw, Sam, McGinlay, Melanie, Simms, Alexander, Gatenby, V. Kate, Sengupta, Anshuman, Levelt, Eylem, Witte, Klaus K., Kearney, Mark T., Cubbon, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715809/ https://www.ncbi.nlm.nih.gov/pubmed/35796239 http://dx.doi.org/10.1002/ehf2.14051

Ejemplares similares

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Diabetes mellitus and the causes of hospitalisation in people with heart failure
por: Malik, Anam, et al.
Publicado: (2022)

Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2021)

Prioritizing symptom management in the treatment of chronic heart failure
por: Koshy, Aaron O., et al.
Publicado: (2020)

Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
por: McGinlay, Melanie, et al.
Publicado: (2022)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2020)

Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial
por: Paton, Maria F., et al.
Publicado: (2021)

Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2021)

Correction: Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2022)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
por: Gierula, John, et al.
Publicado: (2022)

Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study
por: Drozd, Michael, et al.
Publicado: (2021)

An enormous right atrial myxoma highlights the role of echocardiography in heart failure pathways: a case report
por: Straw, Sam, et al.
Publicado: (2022)

Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes
por: Chowdhary, Amrit, et al.
Publicado: (2022)

Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study
por: Kearney, Jessica, et al.
Publicado: (2021)

Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes
por: Thirunavukarasu, Sharmaine, et al.
Publicado: (2021)

Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure
por: Witte, Klaus K, et al.
Publicado: (2018)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study
por: Brown, Oliver I., et al.
Publicado: (2023)

Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy
por: Caspi, Talia, et al.
Publicado: (2020)

Prospective Longitudinal Characterization of the Relationship between Diabetes and Cardiac Structural and Functional Changes
por: Chowdhary, Amrit, et al.
Publicado: (2022)

Systemic Inflammation Is Associated With Future Risk of Fatal Infection: An Observational Cohort Study
por: Drozd, Michael, et al.
Publicado: (2022)

A 30-Year-Old Man With Primary Cardiac Angiosarcoma
por: Jex, Nicholas, et al.
Publicado: (2021)

Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study
por: Drozd, Michael, et al.
Publicado: (2021)

Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy
por: Jex, Nicholas, et al.
Publicado: (2022)

Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure
por: Cubbon, Richard M., et al.
Publicado: (2018)

Secondary mitral regurgitation: reducing the leak, expanding the science
por: Straw, Sam, et al.
Publicado: (2020)

‘Acute Heart Failure’: Should We Abandon the Term Altogether?
por: Straw, Sam, et al.
Publicado: (2022)

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction
por: Mercer, Ben N., et al.
Publicado: (2018)

Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Walker, Andrew M. N., et al.
Publicado: (2018)

Low-frequency attenuation filter as a reversible cause of inappropriate shocks due to myopotential oversensing
por: Patel, Peysh A., et al.
Publicado: (2021)

Outcomes following cardiac resynchronisation therapy in older people
por: Safdar, Nawaz Z, et al.
Publicado: (2023)

Live Simultaneous Monitoring of Mineral Deposition and Lipid Accumulation in Differentiating Stem Cells
por: De Melo, Nigel, et al.
Publicado: (2019)

COVID‐19 and protected areas: Impacts, conflicts, and possible management solutions
por: Jones, Nikoleta, et al.
Publicado: (2021)

Improving the management of left ventricular thrombus in a tertiary cardiology centre: a quality improvement project
por: Rahunathan, Nithusa, et al.
Publicado: (2023)

Hypoxia signalling in the regulation of innate immune training
por: Eades, Lauren, et al.
Publicado: (2022)

Metabolic remodelling in diabetic cardiomyopathy
por: Chong, Cher-Rin, et al.
Publicado: (2017)

Detrimental Immediate- and Medium-Term Clinical Effects of Right Ventricular Pacing in Patients With Myocardial Fibrosis
por: Saunderson, Christopher E.D., et al.
Publicado: (2021)

Global microvascular ischaemia following Takotsubo cardiomyopathy with left ventricular function recovery
por: Chowdhary, Amrit, et al.
Publicado: (2021)

A case report of refractory angina in a patient with diabetes and apical hypertrophic cardiomyopathy
por: Jex, Nicholas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pt40sqi9pjg7170sf2mdh6i8j0